Exacerbation of atrial fibrillation related to dulaglutide use.

Autor:	Lee J; School of Pharmacy, Philadelphia College of Osteopathic Medicine - Georgia Suwanee GA USA., Umana IE; Graduate Medical Education Internal Medicine Residency Program Northeast Georgia Medical Center Gainesville GA USA., Nguyen J; School of Pharmacy, Philadelphia College of Osteopathic Medicine - Georgia Suwanee GA USA.; Philadelphia College of Osteopathic Medicine - Georgia Suwanee GA USA.
Jazyk:	angličtina
Zdroj:	Clinical case reports [Clin Case Rep] 2021 May 15; Vol. 9 (5), pp. e04223. Date of Electronic Publication: 2021 May 15 (Print Publication: 2021).
DOI:	10.1002/ccr3.4223
Abstrakt:	Dulaglutide is associated with sinus tachycardia, increased PR interval, and 1st degree AV block. These conduction abnormalities can increase the risk of arrhythmia. Dulaglutide should be used with caution in patients with pre-existing arrhythmia. Competing Interests: All authors have no conflict of interest to disclose. (© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu PDF